Antengene Corporation Limited (HKG:6996)
Hong Kong · Delayed Price · Currency is HKD 3.400
+0.030 (0.89%)
Jun 18, 2026, 11:55 AM HKT
Antengene Corporation Market Cap
Antengene Corporation has a market cap or net worth of 2.29 billion as of June 17, 2026. Its market cap has decreased by -11.57% in one year.
Market Cap
2.29B
Enterprise Value
1.75B
Revenue
117.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.40
Market Cap Chart
Since November 20, 2020, Antengene Corporation's market cap has decreased from 12.21B to 2.29B, a decrease of -81.26%. That is a compound annual growth rate of -25.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.29B | -11.08% |
| Dec 31, 2025 | 2.57B | 482.90% |
| Dec 31, 2024 | 441.64M | -67.28% |
| Dec 29, 2023 | 1.35B | -61.17% |
| Dec 30, 2022 | 3.48B | -46.78% |
| Dec 31, 2021 | 6.53B | -43.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 2.97B |
| Shandong Boan Biotechnology | 2.91B |
| BioDlink International Company | 2.54B |
| PegBio | 2.51B |
| TYK Medicines | 2.48B |
| Viva Biotech Holdings | 2.39B |
| Beijing Luzhu Biotechnology | 2.39B |
| AIM Vaccine | 2.34B |